key: cord-0896160-nbmii9jc
authors: Kessler, Benedikt M.
title: Chapter 477 Otubains
date: 2013-12-31
journal: Handbook of Proteolytic Enzymes
DOI: 10.1016/b978-0-12-382219-2.00476-2
sha: 5231e9f8a2d263bddba5abe34ad434b730da0e33
doc_id: 896160
cord_uid: nbmii9jc

The third edition of the Handbook of Proteolytic Enzymes aims to be a comprehensive reference work for the enzymes that cleave proteins and peptides, and contains over 800 chapters. Each chapter is organized into sections describing the name and history, activity and specificity, structural chemistry, preparation, biological aspects, and distinguishing features for a specific peptidase. The subject of Chapter 476 is Otubains. Keywords: Otubains, deubiquitylating enzymes, Ubiquitin, Ubiquitin-like proteins, interferon-stimulated genes, Ubiquitin processing enzymes, crystal structure, interferon stimulated genes, ISG15, DUB, OTU, poly-Ubiquitin chains, signal transduction, protein degradation, protein targeting.

Choi, H.R., Batsakis, J.G., Callender, D.L., Prieto, V.G., Luna, M.A., El-Naggar, A.K. (2002) . Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma? Am. J. Surg. Pathol. 26 (6) [32] Ströbel, P., Zettl, A., Ren, Z., Starostik, P., Riedmiller, H., Störkel, S., Müller-Hermelink, H.K., Marx, A. (2002) . Spiradenocylindroma of the kidney: clinical and genetic findings suggesting a role of somatic mutation of the CYLD1 gene in the oncogenesis of an unusual renal neoplasm. Am. J. Surg. Pathol. 26 (1), 119À124. [33] Zhong, S., Fields, C.R., Su, N., Pan, Y.X., Robertson, K.D. (2007) .

Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene 26 (18) OTU containing proteins have a sequence encoding a cysteine protease signature that is conserved across plants, viruses to higher eukaryotes. Approximately 100 genes are known to encode OTU domains, and research in recent year has shed light on the biological function of a considerable number of these enzymes establishing their role as Ubiquitin and Ubiquitin-like (Ubl) processing/deubiquitylating enzymes (DUBs). Structural studies of mammalian and viral OTUs reveal a substantial variety in Ubiquitin binding modes, and viral OTUs appear to have acquired the ability to also recognize ISG-15. OTUs play a role in cell biological processes such as ERAD (YOD1), but also immune signaling (Cezanne, DUBA, and OTUB1) and host-pathogen interactions (OTUB1/ OTUB2, vOTUs). In this chapter, most recent advances in characterizing the biological functions of members of this DUB enzyme family are discussed.

Sequence comparison bioinformatics revealed an evolutionary conserved domain encoding a cysteine protease motif [3] . This motif was first characterized in a gene that is involved in the development of the Drosophila melanogaster ovary (termed otu gene) where it may regulate the localization and translation of certain RNA transcripts [4, 5] . Using the Drosophila otu gene and its homologs as a starting point, sequence similarities were found between these genes and those encoding viral and plant cysteine proteases.

First functional evidence for general DUB-like activity of OTU domain containing proteins, as demonstrated for OTUB1 (HSPC263), was provided by a chemical proteomics screen using Ubiquitin-based active site probes containing C-terminal elecrophilic groups acting as suicide inhibitors [6] . In subsequent studies, Otubain-1 and Otubain-2 were the first two OTU proteins found to display in vitro DUB activity [7] . Shortly thereafter, Cezanne, another OTU-domain containing protein, was found to interact with poly-Ub in a yeast two-hybrid assay and to contain DUB activity in vitro, suggesting that this is a general OTU feature [8] . Since the discovery of the first ovarian tumor domain (OTU) protease in Drosophila oogenesis and prior to the identification of vOTU, OTU superfamily members could be divided into two subclasses according to their sequence homology, otubains (MEROPS peptidase family C65) and A20-like OTUs including ZRANB1 (MEROPS peptidase family C64). With the addition of the viral OTU subclass, OTU superfamily members count more than 100 eukaryotic, bacterial, and viral proteins have now been identified (for examples, see Table 477 .1). Predominantly, OTU proteases have been linked to Ubiquitin (Ub) and Ubiquitin-like protein (Ubl) removal and/or remodeling of Ub/Ublconjugated proteins, placing them among the protease superfamilies that facilitate signal transduction cascades and play key roles in protein stability [9] .

Sequence comparison of the catalytic regions of OTUs reveals a conserved Cys and His residues (Figure 477.1) . However, the position of the acidic residue(s) is variable, and the amino acid side chains involved in the hydrogen bonding network responsible for rendering the catalytic thiol more nucleophilic are not always clearly evident from the primary sequence. In attempts to better understand the biological function of proteins belonging to the OTU superfamily, structures of several OTUs and OTU domains have been elucidated. The crystal structure of human OTUB2 confirmed the typical papain-like cysteine protease fold of the OTU domain (Figure 477 .2A, left panel) and shows that, unlike other cysteine protease DUBs, the catalytic triad is incomplete and is stabilized by a new method involving a hydrogen bonding network (Figure 477 .2A, right panel) [10] . Subsequent X-ray host-pathogen interactions. It remains to be seen whether any of the vOTUs may also show reactivity to the other interferon-induced Ubl FAT10, and whether the unique structural properties of vOTUs can be exploited for pharmacological inhibition based on small-molecule strategies as novel antiviral agents.

Mammalian and viral OTU genes have been cloned and expressed as recombinant enzymes in bacterial expression systems. Some of these constructs are available commercially (ENZO Life Sciences, Life Sensors, Boston Biochem), but the majority of them are only available through academic research groups.

Biological Aspects A20 and Inflammation A20 was first characterized in human umbilical vein endothelial cells predominantly induced by the cytokines TNFα, IL-1β, and LPS [19] . A20 is also known as tumor necrosis factor-a-induced protein 3 (TNFAIP3). Analysis of the A20 domain revealed seven repeats of an A20-type zinc finger (ZnF-A20) in one single polypeptide chain, which exhibits E3 ligase activity, modulating the ubiquitylation status of key adaptors in the NF-κB signaling cascade [20, 21] . The OTU domain that contains DUB protease activity is located at the N-terminus of A20.

Overexpression of A20 inhibits TNF-mediated cell death and down-regulates NF-κB signaling. Upon treatment with TNF, A20 expression was found to increase in variety of cells [20] . Mice deficient in A20 were prone to inflammation, and persistent activation of NF-κB by Tolllike and TNF receptors was observed in these mice [22] . Thus, A20 is critical for limiting inflammation by terminating TNF induced NF-κB responses in vivo. The constitutive expression of A20 in different cell types prevents TNFα-induced cell apoptosis. Furthermore, it has been reported that a loss of A20 expression increased the lethality of TNF-α and lipopolysaccharides due to activation of NF-κB [23] . The importance of A20 as a modulator of immunopathology is underpinned by the genetic association between several mutations in the human A20 locus and immunopathologies such as Crohn's disease, rheumatoid arthritis, systemic lupus erythematosus, psoriasis and type 1 diabetes [24, 25] . More recently, A20 was discovered to interact with the E3 ligase RNF11 and the E2 enzymes UBC13 Ubc5c, the latter of which antagonizes the activity of the E3 ligases TRAF6, TRAF2 and clAP1, thereby providing a direct mechanism of action of A20 terminating NF-κB activation [26, 27] . Taken together, A20 represents an OTU with a central role in regulating inflammation, and mutations are associated with many autoimmune pathologies as well as B-cell malignancies, such as Hodgkin lymphomas [28] .

A number of other DUBs, in particular OTUs, have been found to also play a role in immune signaling pathways. Interferon type I (IFN-I) responses are triggered by pattern-recognition receptors (PRRs), and DUBA (OTUD5) was shown to negatively regulate this immune signaling pathway [29] . DUBA directly binds tumor necrosis factor receptor-associate factor 3 (TRAF3) and cleaves its K63linked polyubiquitin chains, and its expression is suppressed during IL-1R1 stimulation [30] . Two additional A20-like proteins have been identified and shown to play a role in immune signaling pathways. Cellular zinc finger anti-NF-κ B (Cezanne) and TRAF binding domain (TRABID) appear to interact with TRAF6 [31] . Cezanne has a negative effect on NF-κB activation, whereas TRABID activates Wnt-induced transcription [32] . These OTUs may also have other as yet undiscovered biological functions, as TRABID appears to have a preference of cleaving K29-linked over K63linked polyubiquitin chains [33] .

A different subset of OTUs is involved in endoplasmic reticulum and Golgi associated biology. Initially, the AAA-ATPase p97/p47 complex was discovered to be required for heterotypic fusion of transport vesicles and assembly of mitotic Golgi fragments, and VCIP135 (VCIPI1) identified as an essential associated factor [34, 35] . More recent studies on p97ATPase-mediated membrane fusion revealed that VCIP135 deubiquitylating activity is required for the p97/p47-but not the p97/p37dependent pathway [36] . YOD1 (OTU1/OTUD2), another OTU family member, is directly implicated in the dislocation of misfolded proteins from the ER to the cytosol [37] .

OTUB1 is abundantly expressed in most tissues [7] and was originally described as part of a complex including the E3 Ubiquitin ligase GRAIL (gene related to activation in lymphocytes) and USP8, and involved in regulating Tcell anergy [38] . However, OTUB1's ubiquituous expression profile predicts that it has additional biological roles not restricted to the lymphocytic lineage. Indeed, levels of oestrogen receptor α, TRAF3/6 and the small GTPase RhoA were suggested to be modulated by OTUB1 through direct deubiquitylation or indirect effects [39À41]. In addition, OTUB1 was found to regulate p53 stability [42] and bind UBC13 [43] . The latter negatively affects the Ubiquitin ligase RNF168 resulting in an inhibition of the DNA damage response [44] . The interaction with UBC13 and stabilization of p53 appear to be independent of its deubiquitylation activity (non-canonical effect), which may represent a different way that OTUs and perhaps other DUBs can function. The fact that OTUB1 binds UBC13 may have affects on other UBC13 dependent E3 ligases, which could explain its pleiotropic affect on many different (indirect) substrates. OTUB1 has DUB-like activity with an almost exclusive preference for K48-linked poly-Ubiquitin [7, 13] , suggesting that it may have DUB enzyme activity-dependent and independent functions.

The Ubiquitin-like protein ISG15 (Interferon stimulated gene 15) resembles a di-Ubiquitin moiety and mediates an antiviral response to certain viruses. Nairoviruses and Arteriviruses, two unrelated groups of RNA viruses, encode for ovarian tumor domain-containing sequences [45, 46] . These viral OTUs appear to be expressed and to exert DUB-like activity as well as the ability to recognize and cleave ISG15, thereby inhibiting Ubiquitin and ISG15-dependent antiviral pathways [47] . For instance, for the porcine reproductive and respiratory syndrome (PRRS) virus, it was shown that the N-terminal part of the non-structural protein 2 (nsp2) inhibits NF-κB activation [48] . In addition, the Artevirus and Nairovirus OTUs target RIG-1-like receptors, a family of cytosolic RNA helicases that with Toll-like receptors (TLRs) belong to the family of pattern recognition receptors. In the case of Artevirus and Nairovirus derived OTUs, RIG-1 is deubiquitylated, thereby interfering with the signal induced by recognizing foreign RNA [49] . VOTUs are unique in that they are the only OTUs to have shown both deubiquitylating and deISGylating activity. In comparison, Otubain1/2 prefer K48-, K63-linked poly-Ub or NEDD8 (neural precursor cell expressed, developmentally downregulated 8) as substrates [7, 13] . A20 and A20-like Cezanne OTU proteases selectively cleave K63-linked poly-Ub target and DUBA also shows preference for K63-linked poly-Ub [8, 20, 29] . This implies a considerable variation of the OTU domain to accommodate extended functionalities, in particular in viral genes to exploit the modulation of host-pathogen interactions.

The reader is directed to Reyes-Turcu et al. [1] , Nijman et al. [2] , Sowa et al. [43] , and Frias-Staheli et al. [47] .

Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes

A genomic and functional inventory of deubiquitinating enzymes

A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae

Hrb27C, Sqd and Otu cooperatively regulate gurken RNA localization and mediate nurse cell chromosome dispersion in Drosophila oogenesis

Sequence and structure of the Drosophila melanogaster ovarian tumor gene and generation of an antibody specific for the ovarian tumor protein

Chemistrybased functional proteomics reveals novel members of the deubiquitinating enzyme family

Otubains: a new family of cysteine proteases in the ubiquitin pathway

A novel type of deubiquitinating enzyme

A new map to understand deubiquitination

Crystal structure of human otubain 2

Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 Å resolution

Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14

Structural basis and specificity of human otubain 1-mediated deubiquitination

Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein

Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains

Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin

Structural basis for the removal of ubiquitin and interferonstimulated gene 15 by a viral ovarian tumor domain-containing protease

Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease

Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1

Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology

A20 edits ubiquitin and autoimmune paradigms

The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signalling

Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes

A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme

DUBA: a deubiquitinase that regulates type I interferon production

Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production

Isolation and characterization of two novel A20-like proteins

Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains

Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase

VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo

VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments

VCIP135 deubiquitinase and its binding protein, WAC, in p97ATPase-mediated membrane fusion

The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER

Two isoforms of otubain 1 regulate T cell anergy via GRAIL

OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity

Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion

Regulation of virus-triggered signaling by OTUB1-and OTUB2-mediated deubiquitination of TRAF3 and TRAF6

Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1

Defining the human deubiquitinating enzyme interaction landscape

Noncanonical inhibition of DNA damage-dependent ubiquitination by OTUB1

Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein

Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment

Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses

The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions

Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling

Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone

Involvement of KDM1C histone demethylase-OTLD1 otubain-like histone deubiquitinase complexes in plant gene repression

Structure of the A20 OTU domain and mechanistic insights into deubiquitination

Oxford OX3 7BN, UK. Email: bmk@ccmp.ox.ac.uk Handbook of Proteolytic Enzymes, 3rd Edn ©